Medpage Today on MSN10d
Environmentally Friendlier COPD Inhaler May Also Be More Effective
Eligible patients had COPD, were ages 40 or older, and were new initiators of these inhalers from 2021 to 2023. They were ...
News Medical on MSN3d
Study finds no clinical advantage of budesonide inhaler over fluticasone in COPD
A study compares budesonide-glycopyrrolate-formoterol and fluticasone-umeclidinium-vilanterol, revealing insights on COPD ...
Study compares single-inhaler triple therapies for treatment of COPD
For patients with chronic obstructive pulmonary disease (COPD), budesonide-glycopyrrolate-formoterol does not improve ...
MyNewsLA on MSN1h
Cedars: Pulmonologists Stand By to Treat Patients
Pulmonologists expecting to see an increase in individuals with respiratory issues due to the ongoing fires in Los Angeles County have added time for patients to their clinic schedules, Cedars-Sinai ...
pulmonologyadvisor1d
COPD: Early Disease May Be Linked to Impaired FEV1/FVC Trajectories, Wheezing
Individuals with early-onset COPD and rapidly progressive pre-COPD frequently have a decades-long history of impaired ...
First for Women on MSN2h
Doctors Reveal the Best Cold Medicine for Adults Based on Your Symptoms
When a cold strikes, you want fast, effective relief. And while grabbing the first over-the-counter cold medication seems ...
Aer Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial of Fexlamose in Chronic Obstructive Pulmonary Disease
Study AER-01-002 is using a novel and precision imaging strategy to enroll 100 mucus plug-high chronic obstructive pulmonary ...
Trump took on big tobacco before and won. He can win again by targeting smoking. | Opinion
Making America Healthy Again’ is a complicated, messy, and massive undertaking bound to meet resistance. Reducing nicotine in ...